Class IIITerminatedD-0790-2022
Drug recall · May 4, 2022
Cyanocobalamin Injection recall
Why: Subpotent Drug: Out of specification for assay.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Cyanocobalamin Injection, USP, 1000 mcg per mL, For Intramuscular or Subcutaneous Use Only, 25 x 1 mL Vials, Rx only, Manufactured by: Eugia Pharma Specialties Limited, Hyderabad India for BluePoint Laboratories. NDC for Carton: 68001-509-60; NDC for vial: 68001-509-59
- Lots / codes
Lots: CCC210008, CCC210009, Exp. 01/23
- Quantity
- 97,975 vials
- Company
- American Health Packaging, Columbus, OH
- Distribution
- Alabama
- Initiated
- April 12, 2022 · Voluntary: Firm initiated
- Classified
- April 26, 2022
- Reported
- May 4, 2022
- Ended
- December 28, 2022
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.